Cabometyx is approved for treating well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors in patients 12 years and older ... They can cause painful rash in the hands and feet, ...

There are two main types of pancreatic cancer, based on the type of cell that the tumor develops in. The two main types are exocrine and neuroendocrine ... like fatigue, skin irritation in ...

It’s important to note that antithyroid medications used to treat hyperthyroidism may cause hives or a skin rash ... symptoms that develop from neuroendocrine tumors. While considered rare ...

Physiologically, it occurs when blood vessels just below the surface of the skin, called capillaries ... Some patients with medullary thyroid cancers, pancreatic neuroendocrine tumors, and endogenous ...

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

well-differentiated pancreatic neuroendocrine tumors (pNET) and extrapancreatic NET (epNET). Specifically, the approval is for those with unresectable, locally advanced, or metastatic pNET and ...

Cabozantinib significantly delayed disease progression in advanced pancreatic and extra-pancreatic neuroendocrine tumors, as shown in the phase 3 CABINET trial. The trial demonstrated a median PFS ...

Jennifer Chan, MD, MPH, discussed outcomes of treating neuroendocrine tumors (NETs) with cabozantinib depending on whether they were pancreatic NETs or extrapancreatic NETs.

Pancreatic cysts are fluid-filled sacs that can form in the pancreas. Some remain benign, while others have the potential to ...

The DAMO PANDA can accurately detect pancreatic cancer lesions, and FDA breakthrough therapy designation aims to accelerate ...